Retatrutide In the first phase 3 trial (TRIUMPH-4), participants lost an average of 28.7% of their body weight at 68 weeks on the highest dose (12mg), with the 9mg dose showing 26.4% weight loss
It helps regulate blood sugar, slows digestion, increases feelings of fullness, and signals the brain to reduce appetite
The expansion of GLP-1 indications into cardiovascular health, sleep apnea, and potentially even neurological conditions only adds further pressure to an already strained pharma supply chain
One AssuredPartners case study found GLP1 users saved about $560 per person per year in medical costs but against an average annual drug cost of $6,540, the nearterm ROI is negative for most employers
With options ranging from Ozempic to Victoza, understanding the nuances in weight loss efficacy and blood sugar control is crucial